Benefit-based interventions to address chronic disease compliance generally involve one of two approaches. The most common strategy is to exempt classes of drugs from copayments or coinsurance; a less tested strategy is to exempt classes of patients (i.e., diabetics) from cost sharing. Do such interventions improve health outcomes, and do they save money?

This report provides a review of the literature on the public health impacts of paid sick leave. To date, research in this area has been somewhat limited. Generally speaking, the literature focuses on a few key industries and illnesses. These include the commercial food, health-services and child-care industries, and common illnesses such as gastrointestinal and respiratory infections.

A research report showing that the proposed California paid sick days legislation will have significant positive public health impacts.